News
Genetic testing company 23andMe is preparing for a renewed auction of its assets after a federal judge agreed to reopen the ...
The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...
1d
Newser on MSN23andMe Sale Takes a New TurnThe sale of genetic testing company 23andMe—which includes genetic data from around 16 million customers—took a new turn at a ...
Once a Silicon Valley pioneer in consumer genetic testing, 23andMe is now at the center of a high-stakes legal and financial ...
The fate of genetic data belonging to millions of 23andMe customers is again up in the air, as the bankrupt company seeks a ...
Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...
There are standard solutions to the problem, but they are only partial solutions: In the past few months, I have written a ...
Bankrupt genetic testing company 23andMe is looking to sell its assets — most notably its customers' DNA data — for more than ...
Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...
A buyer had actually already been found for 23andme, but a competitor is not giving up: The ex-boss of the company may have ...
2d
Investor's Business Daily on MSN23andMe Angles For A Bigger Regeneron Bid As Ex-CEO Steps Up With A Better OfferMe wants to reopen bidding on its assets after former CEO Anne Wojcicki put together a $305 million offer, topping Regeneron.
Court filings give insight into why shooting suspect Louis Mangione might have targeted the UnitedHealthcare executive: "It checks every box." In other news: Hospital construction trends include AI; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results